Accidentally Trashed, Thawed or Expired: Reports of Covid Vaccine Spoilage
As the speed of covid vaccinations picks up, so do the reports of doses going to waste. Health officials are trying to rein in waste without slowing down vaccinations.
Drugs
541 - 560 of 1,300 Results
-
-
In California, Caregivers of People With Disabilities Are Being Turned Away at COVID Vaccine Sites
Parents and caregivers of people with disabilities in California are supposed to be near the front of the line for the covid-19 vaccine. But some are hitting roadblocks at vaccination sites.
-
Why AstraZeneca and J&J鈥檚 Vaccines, In Use Elsewhere, Are Still on Hold in America
Covid has pressed the Food and Drug Administration into its fastest vaccine reviews ever 鈥 which are still painfully slow, critics say.
-
After Billions of Dollars and Dozens of Wartime Declarations, Why Are Vaccines Still in Short Supply?
The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfangled vaccines have required herculean logistical efforts.
By Rachana Pradhan and Arthur Allen -
KHN鈥檚 鈥榃hat the Health?鈥: Open Enrollment, One More Time
Keeping a campaign promise, President Joe Biden has reopened enrollment for health coverage under the Affordable Care Act on healthcare.gov 鈥 and states that run their own health insurance marketplaces followed suit. At the same time, the Biden administration is moving to revoke the Trump administration鈥檚 permission for states to impose work requirements for some adults on the Medicaid health insurance program. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also, Rovner interviews medical student Inam Sakinah, president of the new group Future Doctors in Politics.
-
Can Pfizer and Moderna End the Pandemic by Sharing Their Vaccine Designs? It’s Not that Simple
Industry experts say it鈥檚 highly unlikely that dozens of pharmaceutical companies that aren鈥檛 already producing covid vaccines stand ready to do so.
-
As Drug Prices Keep Rising, State Lawmakers Propose Tough New Bills to Curb Them
The measures would impose taxes on increases in the price of drugs that don鈥檛 reflect improved clinical value and set the rates paid by state-run and commercial health plans to a benchmark based on prices in Canada.
By Harris Meyer -
Farmworker Camps to Urban Tent Cities: Tailoring Vaccine Info to Where It鈥檚 Most Needed
Concerns arising in western North Carolina provide a window into the challenges facing health workers across the country as they seek to persuade vulnerable populations to be inoculated against covid.
-
KHN鈥檚 鈥榃hat the Health?鈥: Covid and Kids
Can schools safely reopen before all teachers and staffers are vaccinated against covid? And what鈥檚 the best way to communicate that science 鈥 and scientific recommendations 鈥 change and evolve? Also, get ready for a redo of open enrollment for Affordable Care Act coverage, this time with help and outreach to find those eligible. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss these issues and more.
-
100 Million Covid Shots in 100 Days Doesn鈥檛 Get Us Back to Normal
President Joe Biden鈥檚 promise to reach this milestone is an important step forward in vaccine rollout. But it is only the beginning of the sweeping vaccination effort required.
-
When Your Chance for a Covid Shot Comes, Don鈥檛 Worry About the Numbers
The Johnson & Johnson vaccine that the FDA cleared Saturday was 66% effective overall in preventing moderate to severe covid, while the Pfizer and Moderna vaccines were more than 90% effective. But the numbers aren鈥檛 exactly comparable. And all three shots prevent hospitalization and death.
By Arthur Allen and Liz Szabo -
States Move Ahead With Canada Drug Importation While Awaiting Signal From Biden
As president, Donald Trump encouraged states to bring in drugs from Canada, where prices are cheaper. It鈥檚 not clear if the new administration will follow suit.
-
KHN鈥檚 鈥榃hat the Health?鈥: The Long Road to Unwinding Trump Health Policies
President Joe Biden signed a pair of health-related executive orders this week that would, among other things, reopen enrollment under the Affordable Care Act and start to reverse former President Donald Trump鈥檚 anti-abortion policies. Meanwhile, Congress remains bogged down with taking up the next round of covid-19 relief. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Shefali Luthra of The 19th join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for 鈥渆xtra credit,鈥 the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead 鈥 Boosted by Taxpayers
With U.S. cases skyrocketing, demand for Gilead鈥檚 dark horse antiviral is only growing. Biden appointees propose potential legal tactics to tamp down the price for patients.
-
Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster
Even invoking the widely heralded Defense Production Act to pressure drugmakers wouldn鈥檛 overcome vast obstacles.
-
Health Issues Carried Weight on the Campaign Trail. What Could Biden Do in His First 100 Days?
KHN has teamed up with PolitiFact to track what becomes of President Joe Biden鈥檚 2020 campaign promises over the next four years. As he moves into the West Wing, what are his chances of making progress on health care?
-
Are Public Health Ads Worth the Price? Not if They鈥檙e All About Fear
Public service announcements about drug use or other public health problems often fall short, public health marketing experts say, because they incite people鈥檚 worst fears rather than giving people solutions.
By Eric Berger -
KHN鈥檚 鈥榃hat the Health?鈥: On Capitol Hill, Actions Have Consequences
Several large business groups, including health industry organizations, are cutting off contributions to Republicans who voted against the certification of Joe Biden鈥檚 election even after riots shut down the Capitol on Jan. 6. Meanwhile, the outgoing Trump administration not only approved a Medicaid block grant for Tennessee, but also made it difficult for the incoming Biden administration to undo. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Kimberly Leonard of Business Insider join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN鈥檚 Victoria Knight about the latest KHN-NPR 鈥淏ill of the Month鈥 episode.
-
Delicate Covid Vaccines Slow Rollout 鈥 Leading to Shots Given Out of Turn or, Worse, Wasted
鈥淭haw. Rest 15 minutes. Do not shake. Do not refreeze.鈥滵o not shake. Do not refreeze.鈥 Moderna鈥檚 vaccine comes with complicated instructions. And both available vaccines are good for only six hours once the vial is open. So at day鈥檚 end, health workers are left to either throw out precious doses or get shots into any arm that鈥檚 available.
-
Is Your Covid Vaccine Venue Prepared to Handle Rare, Life-Threatening Reactions?
More than two dozen people who have received the new covid vaccines in U.S. hospitals and health centers suffered anaphylaxis, a potentially fatal allergic reaction. While such severe reactions are rare, experts warn that the drugstores and drive-thru clinics considered integral to the vaccine rollout must be prepared.